CAPS Rating

CheapHessian (< 20)

Results 1 - 20 of 45 : 1 2 3 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
17/03/2014 TGD.US 1 out of 5 Outperform 5Y $1.70 $0.61 (+5.08%) -63.83% +13.57% -77.40
17/03/2014 FNV.US 4 out of 5 Outperform 5Y $51.59 $49.67 (+0.87%) -3.72% +13.57% -17.29
17/03/2014 LODE.US 1 out of 5 Outperform 5Y $1.94 $0.78 (-2.49%) -59.79% +13.57% -73.36
17/03/2014 GDXJ.US 3 out of 5 Outperform 5Y $44.00 $24.93 (+2.97%) -43.34% +13.57% -56.91
17/03/2014 AEM.US 3 out of 5 Outperform 5Y $33.93 $30.10 (+0.94%) -11.30% +13.57% -24.87
17/03/2014 ANVGQ.US 2 out of 5 Outperform 5Y $6.37 $0.21 (-9.14%) -96.77% +13.57% -110.34
17/03/2014 GG.US 3 out of 5 Outperform 5Y $27.71 $19.18 (+0.89%) -30.79% +13.57% -44.35
29/02/2012 16/03/2014 AMZN.US 3 out of 5 Underperform 3Y $179.70 $438.56 (-1.47%) +144.05% +53.47% -90.59
26/02/2013 EXK.US 3 out of 5 Outperform 5Y $6.21 $2.03 (+6.84%) -67.31% +40.78% -108.09
11/02/2013 FSM.US 2 out of 5 Outperform 5Y $4.47 $3.67 (+0.55%) -17.90% +38.90% -56.80
11/02/2013 PAAS.US 3 out of 5 Outperform 5Y $15.93 $9.50 (+3.49%) -40.36% +38.90% -79.26
05/02/2013 RIC.US 2 out of 5 Outperform 5Y $3.20 $3.20 (+0.63%) 0% +40.19% -40.19
05/02/2013 AXU.US 4 out of 5 Outperform 5Y $4.58 $0.40 (+7.57%) -91.19% +40.19% -131.38
04/02/2013 SSRI.US 3 out of 5 Outperform 5Y $12.09 $5.51 (+5.15%) -54.43% +40.21% -94.64
04/02/2013 GORO.US 2 out of 5 Outperform 5Y $12.39 $3.41 (+0.89%) -72.47% +40.21% -112.68
24/01/2013 SGSVF.US 2 out of 5 Outperform 5Y $2.51 $0.27 (+0.33%) -89.21% +41.31% -130.53
23/01/2013 NRT.US 5 out of 5 Outperform 1Y $20.75 $13.63 (+2.43%) -34.31% +41.33% -75.64
23/01/2013 POT.US 5 out of 5 Outperform 5Y $38.08 $32.99 (-1.08%) -13.37% +41.33% -54.70
23/01/2013 CPE.US 2 out of 5 Outperform 5Y $5.22 $8.53 (-3.29%) +63.41% +41.33% +22.08
14/01/2013 IAG.US 3 out of 5 Outperform 5Y $10.58 $2.21 (+4.25%) -79.11% +43.49% -122.60
Results 1 - 20 of 45 : : 1 2 3 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.